KingMylab

KingMylab is a leading China-based central laboratory and data services provider for global clinical trials. With experience supporting over 600 companies across nearly 4,000 trials, we offer end-to-end lab solutions from clinical to post-marketing phases. Our CAP/CLIA-accredited labs in Guangzhou, Shanghai, and Hong Kong, combined with international partnerships, ensure compliant, high-quality services in oncology, immunology, cell/gene therapy, and more. We are dedicated to accelerating drug development worldwide through integrated, innovative laboratory support.